chr1:208054317:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr1:208,054,317-208,084,747 |
hg38 | chr1:207,880,972-207,911,402 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.004 | squamous cell carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Carcinoma, Transitional Cell | NA | BeFree | Detail | |
0.003 | Cardiomyopathy, Dilated | NA | LHGDN | Detail | |
<0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
0.120 | Neoplastic Cell Transformation | NA | CTD_human | Detail | |
<0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
<0.001 | choriocarcinoma | NA | BeFree | Detail | |
0.005 | Congenital chromosomal disease | NA | BeFree | Detail | |
<0.001 | ulcerative colitis | NA | BeFree | Detail | |
0.001 | colorectal carcinoma | NA | BeFree | Detail | |
<0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
<0.001 | Coronary heart disease | NA | BeFree | Detail | |
<0.001 | Cyst | NA | BeFree | Detail | |
<0.001 | Cytomegalovirus Infections | Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Der... | BeFree | 25762731 | Detail |
0.001 | Diabetes | NA | BeFree | Detail | |
0.001 | diabetes mellitus | NA | BeFree | Detail | |
<0.001 | diabetic retinopathy | The presence of FAM18B was determined with qRT-PCR in CD34+/VEGFR2+ mononuclear ... | BeFree | 25221423 | Detail |
<0.001 | disseminated intravascular coagulation | NA | BeFree | Detail | |
<0.001 | Down syndrome | NA | BeFree | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
<0.001 | Esophageal Neoplasms | NA | BeFree | Detail | |
<0.001 | Exanthema | NA | BeFree | Detail | |
0.002 | Fanconi anemia | NA | BeFree | Detail | |
<0.001 | Gaucher disease | NA | BeFree | Detail | |
<0.001 | Giant Cell Tumors | NA | BeFree | Detail | |
0.001 | glioblastoma | NA | BeFree | Detail | |
0.001 | Graft-vs-Host Disease | NA | BeFree | Detail | |
0.002 | chronic granulomatous disease | Using a standard platform that combines iPSC generation from peripheral blood CD... | BeFree | 25288370 | Detail |
0.001 | Graves Disease | NA | BeFree | Detail | |
0.002 | Head and Neck Neoplasms | NA | GAD | Detail | |
0.003 | Heat Stroke | NA | LHGDN | Detail | |
0.001 | hemangioma | NA | BeFree | Detail | |
<0.001 | hemangiopericytoma | In summary, when encountering a bland spindle cell neoplasm with classic hemangi... | BeFree | 25416841 | Detail |
<0.001 | Hemangiosarcoma | NA | BeFree | Detail | |
<0.001 | Hematological Disease | Gene therapy for hematological disorders relies on the genetic modification of C... | BeFree | 25189742 | Detail |
<0.001 | hepatitis B | NA | BeFree | Detail | |
0.002 | hepatitis C | NA | GAD | Detail | |
<0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
<0.001 | Histiocytosis, Langerhans-Cell | NA | BeFree | Detail | |
0.016 | HIV Infections | Our strategy underlines the promising future of gene engineering HIV-resistant C... | BeFree,LHGDN | 25903342 | Detail |
<0.001 | Hodgkin Disease | NA | BeFree | Detail | |
0.003 | Hyperplasia | NA | LHGDN | Detail | |
<0.001 | hyperthyroidism | NA | BeFree | Detail | |
0.006 | Immunologic Deficiency Syndromes | Day-7-cultured CD34(+) cells from two of three JMML patients injected intrafemor... | BeFree | 25102944 | Detail |
0.006 | Immunologic Deficiency Syndromes | Transduction of unstimulated CD34(+) cells with CD133-LV resulted in gene markin... | BeFree | 25189742 | Detail |
0.006 | Immunologic Deficiency Syndromes | In order to understand the precise mechanisms involved in human APL leukemogenes... | BeFree | 25369030 | Detail |
0.006 | Immunologic Deficiency Syndromes | Here, we determined that a population of CD34(+) cells isolated from PLC/PRF/5 h... | BeFree | 25519836 | Detail |
0.006 | Immunologic Deficiency Syndromes | Human CD34(+) human cord blood cells were transduced with an FV vector encoding ... | BeFree | 25786870 | Detail |
<0.001 | ischemia | NA | BeFree | Detail | |
0.004 | Fibroid Tumor | CD34 and CD49b are cell surface markers that can be used to enrich a subpopulati... | BeFree,LHGDN | 25658015 | Detail |
0.022 | leukemia | Primitive CD34(+)/CD123(+)/CD38(-) populations enriched for leukemia-initiating ... | BeFree | 25283841 | Detail |
0.022 | leukemia | Including cytogenetic data of fluorescence in situ hybridization analyses of per... | BeFree | 25344522 | Detail |
0.022 | leukemia | In MLL-AF4 patients, CD34(+)CD38(+)CD19(+) and CD34(-)CD19(+) cells initiated le... | BeFree | 25538041 | Detail |
0.022 | leukemia | Ectopic expression of SOX7 in K562 and THP-1 cells, as well as primary CD33(+)CD... | BeFree | 25940713 | Detail |
0.022 | leukemia | Expression of TP53 by CD34-positive cells was associated with shorter OS and leu... | BeFree | 26123119 | Detail |
0.002 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Acute Erythroblastic Leukemia | NA | BeFree | Detail | |
0.002 | lymphoid leukemia | NA | BeFree | Detail | |
0.007 | Acute lymphocytic leukemia | Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged hu... | BeFree | 25538041 | Detail |
0.001 | Leukemia, Lymphocytic, Acute, L1 | We analyzed cells from peripheral blood and CD34-/CD34+ cells from bone marrow o... | BeFree | 25244981 | Detail |
<0.001 | Leukemia, Lymphocytic, Acute, L2 | NA | BeFree | Detail | |
<0.001 | Acute Megakaryocytic Leukemias | NA | BeFree | Detail | |
0.069 | Leukemia, Myelocytic, Acute | We analyzed the expression of RIP1 and RIP3 in CD34+ leukemia cells from a cohor... | BeFree,LHGDN | 25144719 | Detail |
0.069 | Leukemia, Myelocytic, Acute | In the mice implanted with AML CD34+ HSPCs, expression inhibition of the miR-181... | BeFree,LHGDN | 25174404 | Detail |
0.069 | Leukemia, Myelocytic, Acute | More importantly, curcumin suppressed FoxM1 expression, selectively inhibited ce... | BeFree,LHGDN | 25179295 | Detail |
0.069 | Leukemia, Myelocytic, Acute | CD34(+) cells from a subset of AML patients displayed higher expression levels o... | BeFree,LHGDN | 25184385 | Detail |
0.069 | Leukemia, Myelocytic, Acute | We performed RNA sequencing of 12 EVI1-r AMLs and compared the results with thos... | BeFree,LHGDN | 25331116 | Detail |
0.069 | Leukemia, Myelocytic, Acute | In this analysis, we have examined the value of aldehyde dehydrogenase (ALDH) ac... | BeFree,LHGDN | 25545165 | Detail |
0.069 | Leukemia, Myelocytic, Acute | Epigenetic analysis of a subset of AML samples also identified common regions of... | BeFree,LHGDN | 25600023 | Detail |
0.069 | Leukemia, Myelocytic, Acute | Ectopic expression of SOX7 in K562 and THP-1 cells, as well as primary CD33(+)CD... | BeFree,LHGDN | 25940713 | Detail |
0.069 | Leukemia, Myelocytic, Acute | We recently found that the tetraspanin family member, CD82, which is aberrantly ... | BeFree,LHGDN | 25955299 | Detail |
0.069 | Leukemia, Myelocytic, Acute | In this study, we report that the expression of the key miRNA processing enzyme ... | BeFree,LHGDN | 25990244 | Detail |
0.069 | Leukemia, Myelocytic, Acute | Signal transducer and activator of transcription 5 (STAT5) is activated in CD34(... | BeFree,LHGDN | 26059451 | Detail |
0.069 | Leukemia, Myelocytic, Acute | Now, our results indicate that high PKR expression in CD34(+) cells of acute mye... | BeFree,LHGDN | 26202421 | Detail |
0.069 | Leukemia, Myelocytic, Acute | Cord Blood-Derived Quiescent CD34+ Cells Are More Transcriptionally Matched to A... | BeFree,LHGDN | 26637397 | Detail |
0.003 | myeloid leukemia | NA | BeFree | Detail | |
0.039 | Myeloid Leukemia, Chronic | Herein, novel polyelectrolyte complexes were used as model carriers for IM in a ... | BeFree,LHGDN | 24364873 | Detail |
0.039 | Myeloid Leukemia, Chronic | Bosutinib/PF-00477736 co-treatment also potentiated cell death in CD34(+) CML pa... | BeFree,LHGDN | 25465126 | Detail |
0.039 | Myeloid Leukemia, Chronic | Using microarray-based miRNA profiling, we found that miRNA 486 (miR-486) is sig... | BeFree,LHGDN | 25515961 | Detail |
0.039 | Myeloid Leukemia, Chronic | Moreover, CC(mut3) inhibits colony formation by primary CML CD34(+) cells ex viv... | BeFree,LHGDN | 25721898 | Detail |
0.039 | Myeloid Leukemia, Chronic | The aim of the study was to identify specific features of functional activity, p... | BeFree,LHGDN | 25879558 | Detail |
0.039 | Myeloid Leukemia, Chronic | Also, ectopic expression of CCNG2 in CD34+ CML cells strongly decreased their cl... | BeFree,LHGDN | 25925206 | Detail |
0.039 | Myeloid Leukemia, Chronic | A similar mechanism was found to operate in primary CML CD34(+) cells. | BeFree,LHGDN | 25965880 | Detail |
0.039 | Myeloid Leukemia, Chronic | Moreover, BAP1 protein levels are low or undetectable in CD34(+) cells from CML ... | BeFree,LHGDN | 26118501 | Detail |
0.039 | Myeloid Leukemia, Chronic | In addition, miR-181a increased IM sensitivity of the CD34+ CML cells. | BeFree,LHGDN | 26554155 | Detail |
0.002 | Leukemia, Myeloid, Chronic-Phase | Expression of IK6 in CD34(+) CP-CML cells also led to activation of signal trans... | BeFree | 25370416 | Detail |
<0.001 | acute myelomonocytic leukemia | GATA2 mutations were closely associated with younger age, FAB M1 subtype, interm... | BeFree | 25241285 | Detail |
0.001 | Leukemia, Myelomonocytic, Chronic | RNA-seq analyses of telomere dysfunctional CMP identified aberrantly spliced tra... | BeFree | 25965571 | Detail |
0.011 | acute promyelocytic leukemia | These findings demonstrate that CMP are a target fraction for PML-RARA in APL, w... | BeFree,LHGDN | 25369030 | Detail |
<0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
<0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
0.003 | Leukocytosis | NA | LHGDN | Detail | |
0.003 | liver cirrhosis | A significant increase in both CD34⁺ and CD133⁺ cells was found in CHB and cirrh... | BeFree,LHGDN | 25425463 | Detail |
0.003 | Liver diseases | NA | LHGDN | Detail | |
<0.001 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
<0.001 | lymphangioma | NA | BeFree | Detail | |
0.003 | lymphoma | NA | BeFree | Detail | |
<0.001 | Lymphoma, Follicular | NA | BeFree | Detail | |
<0.001 | Lymphoma, Non-Hodgkin | NA | BeFree | Detail | |
<0.001 | malaria | NA | BeFree | Detail | |
<0.001 | Malaria, Cerebral | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
0.003 | paroxysmal nocturnal hemoglobinuria | NA | BeFree | Detail | |
<0.001 | Marfan syndrome | NA | BeFree | Detail | |
<0.001 | mastocytosis | NA | BeFree | Detail | |
0.004 | melanoma | NA | BeFree,LHGDN | Detail | |
<0.001 | meningioma | NA | BeFree | Detail | |
<0.001 | Mesothelioma | NA | BeFree | Detail | |
<0.001 | mitral valve stenosis | NA | BeFree | Detail | |
<0.001 | Monoclonal Gammopathy of Undetermined Significance | NA | BeFree | Detail | |
0.003 | Monosomy | NA | BeFree | Detail | |
<0.001 | Mucopolysaccharidoses | NA | BeFree | Detail | |
0.005 | multiple myeloma | Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hem... | BeFree | 25278456 | Detail |
0.001 | multiple sclerosis | NA | BeFree | Detail | |
<0.001 | Myelodysplasia | NA | BeFree | Detail | |
0.003 | myelofibrosis | Our data indicate that the MF splenic microenvironment is characterized by incre... | BeFree | 25461253 | Detail |
<0.001 | Myeloid Metaplasia | NA | BeFree | Detail | |
0.003 | myocardial infarction | NA | LHGDN | Detail | |
0.003 | Neoplasm Metastasis | Samples from 53 patients with HCC, i.e., 5 with metastasis and 48 without were t... | BeFree | 25337219 | Detail |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
0.002 | nephroblastoma | NA | BeFree | Detail | |
<0.001 | neurilemmoma | NA | BeFree | Detail | |
0.002 | neuroblastoma | Neuroblastoma arginase activity results in inhibition of myeloid cell activation... | BeFree | 26054597 | Detail |
0.003 | Melanocytic nevus | NA | LHGDN | Detail | |
0.002 | orbit (eye disorders) | They putatively infiltrate the orbit in thyroid-associated ophthalmopathy where ... | BeFree | 26287404 | Detail |
<0.001 | Osteoporosis, Postmenopausal | NA | BeFree | Detail | |
0.001 | ovarian carcinoma | NA | BeFree | Detail | |
0.003 | Pancreatic Neoplasm | NA | LHGDN | Detail | |
<0.001 | pancytopenia | NA | BeFree | Detail | |
<0.001 | pituitary adenoma | NA | BeFree | Detail | |
0.006 | polycythemia vera | NA | BeFree | Detail | |
0.003 | polyps | NA | LHGDN | Detail | |
0.005 | Preleukemia | Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in M... | BeFree | 25122688 | Detail |
0.005 | Preleukemia | In the study presented here, the International Prognostic Scoring Systems were v... | BeFree | 25344522 | Detail |
<0.001 | Psychotic Disorders | NA | BeFree | Detail | |
<0.001 | Retinal Diseases | CD34+/VEGFR2+ mononuclear cells from subjects with proliferative diabetic retino... | BeFree | 25221423 | Detail |
<0.001 | Kaposi sarcoma | NA | BeFree | Detail | |
<0.001 | Sickle Cell Trait | NA | BeFree | Detail | |
<0.001 | Skin Neoplasms | NA | BeFree | Detail | |
<0.001 | Soft Tissue Neoplasms | NA | BeFree | Detail | |
0.004 | Stomach Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | Cerebrovascular accident | NA | BeFree | Detail | |
<0.001 | synovial sarcoma | NA | BeFree | Detail | |
<0.001 | teratoma | NA | BeFree | Detail | |
<0.001 | thalassemia | NA | BeFree | Detail | |
<0.001 | Thrombasthenia | NA | BeFree | Detail | |
0.001 | thromboangiitis obliterans | NA | BeFree | Detail | |
0.002 | Thrombocythemia, Essential | HMGA2 mRNA expression, especially variant 1 with 3'UTR that contains MIRLET7-spe... | BeFree | 25236537 | Detail |
<0.001 | Thyroid Diseases | NA | BeFree | Detail | |
<0.001 | thyroiditis | NA | BeFree | Detail | |
0.002 | Tobacco use disorder | NA | GAD | Detail | |
<0.001 | Trisomy | NA | BeFree | Detail | |
<0.001 | urticaria pigmentosa | NA | BeFree | Detail | |
0.001 | Uterine Fibroids | CD34 and CD49b are cell surface markers that can be used to enrich a subpopulati... | BeFree | 25658015 | Detail |
<0.001 | Virus Diseases | NA | BeFree | Detail | |
<0.001 | von Willebrand Disease | NA | BeFree | Detail | |
<0.001 | Wiskott-Aldrich syndrome | NA | BeFree | Detail | |
<0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
<0.001 | Lysosomal Storage Diseases | NA | BeFree | Detail | |
<0.001 | Lymphoma, AIDS-Related | NA | BeFree | Detail | |
0.009 | severe combined immunodeficiency | Human CD34(+) human cord blood cells were transduced with an FV vector encoding ... | BeFree | 25786870 | Detail |
<0.001 | Mucopolysaccharidosis VII | NA | BeFree | Detail | |
0.002 | Neoplasms, Second Primary | NA | GAD | Detail | |
<0.001 | Synovial Cyst | The ganglion-like cells were positive for both CD34 and CD68 but negative for CD... | BeFree | 24857338 | Detail |
0.003 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Hamman-Rich syndrome | NA | BeFree | Detail | |
<0.001 | Depressive Symptoms | NA | BeFree | Detail | |
<0.001 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
<0.001 | Atrophic condition of skin | NA | BeFree | Detail | |
<0.001 | Myocardial Ischemia | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of lung (disorder) | MiRNAs are characteristically expressed in tumor-initiating Sca-1(+) CD34(+) cel... | BeFree | 25359683 | Detail |
<0.001 | esophageal carcinoma | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | proliferative diabetic retinopathy | CD34+/VEGFR2+ mononuclear cells from subjects with proliferative diabetic retino... | BeFree | 25221423 | Detail |
<0.001 | allergic asthma | NA | BeFree | Detail | |
<0.001 | adrenoleukodystrophy | Recently, we demonstrated that of the cell types derived from CD34+ stem cells, ... | BeFree | 25079382 | Detail |
<0.001 | Porphyria, Erythropoietic | NA | BeFree | Detail | |
<0.001 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | Liposarcoma, Dedifferentiated | NA | BeFree | Detail | |
<0.001 | Germ cell tumor | NA | BeFree | Detail | |
<0.001 | Sarcoma, Epithelioid | NA | BeFree | Detail | |
<0.001 | Myelolipoma | NA | BeFree | Detail | |
<0.001 | Histiocytoma, Benign Fibrous | NA | BeFree | Detail | |
<0.001 | germinoma | NA | BeFree | Detail | |
0.003 | Carcinoma, Lobular | NA | LHGDN | Detail | |
<0.001 | Carcinoma, Neuroendocrine | Immunohistochemistry analysis showed that the NEC tumor cells were positive for ... | BeFree | 25674291 | Detail |
<0.001 | cholangiocarcinoma | CD34(+) PLCs that also expressed CD31 and their progeny CD31(+) cells formed CHC... | BeFree | 25519836 | Detail |
0.001 | ganglioglioma | NA | BeFree | Detail | |
<0.001 | Epithelioid hemangioendothelioma | NA | BeFree | Detail | |
<0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
<0.001 | Mastocytosis, Systemic | NA | BeFree | Detail | |
<0.001 | Cyclic neutropenia | NA | BeFree | Detail | |
<0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
0.012 | Gastrointestinal Stromal Tumors | The pathology showed a gastrointestinal stromal tumor that was diagnosed based o... | BeFree,LHGDN | 25645799 | Detail |
0.001 | Hereditary pancreatitis | NA | BeFree | Detail | |
<0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
0.003 | Neoplasm, Residual | NA | BeFree | Detail | |
0.003 | Ventricular Dysfunction, Left | NA | LHGDN | Detail | |
<0.001 | Parasitemia | NA | BeFree | Detail | |
0.002 | Miller Dieker syndrome | MDS-derived MSCs exhibited impaired capacity to support normal CD34(+) myeloid a... | BeFree | 24617415 | Detail |
0.002 | Miller Dieker syndrome | MDS is a disorder of the hematopoietic stem cell and we thus studied the transcr... | BeFree | 25428262 | Detail |
<0.001 | dyskeratosis congenita | NA | BeFree | Detail | |
<0.001 | Vesicular Stomatitis | NA | BeFree | Detail | |
<0.001 | adenosine deaminase deficiency | NA | BeFree | Detail | |
<0.001 | Gaucher Disease, Type 3 (disorder) | NA | BeFree | Detail | |
<0.001 | Shwachman syndrome | NA | BeFree | Detail | |
<0.001 | Disseminated neuroblastoma | NA | BeFree | Detail | |
<0.001 | Cancer of Head and Neck | NA | BeFree | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | Here, we determined that a population of CD34(+) cells isolated from PLC/PRF/5 h... | BeFree | 25519836 | Detail |
<0.001 | untreated adult acute myeloid leukemia | NA | BeFree | Detail | |
<0.001 | adult acute promyelocytic leukemia (M3) | NA | BeFree | Detail | |
0.001 | Acute Undifferentiated Leukemia | For patients with ALDH-numerous AML, the CD34(+) ALDH(+) subset consisted mainly... | BeFree | 25545165 | Detail |
<0.001 | laryngeal squamous cell carcinoma | NA | BeFree | Detail | |
0.001 | secondary acute myeloid leukemia | NA | BeFree | Detail | |
<0.001 | secondary myelodysplastic syndromes | NA | BeFree | Detail | |
<0.001 | Vascular Neoplasms | NA | BeFree | Detail | |
<0.001 | cervix carcinoma | NA | BeFree | Detail | |
<0.001 | Fibrous papule of nose | NA | BeFree | Detail | |
<0.001 | Elastofibroma | The perivascular distribution of periostin and tenascin-C, associated with the C... | BeFree | 25820560 | Detail |
<0.001 | Teratoma, Malignant | NA | BeFree | Detail | |
<0.001 | pilocytic astrocytoma | NA | BeFree | Detail | |
<0.001 | Thyroid associated opthalmopathies | They putatively infiltrate the orbit in thyroid-associated ophthalmopathy where ... | BeFree | 26287404 | Detail |
0.001 | Congenital neutropenia | NA | BeFree | Detail | |
<0.001 | Asymptomatic human immunodeficiency virus infection | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of liver | Here, we determined that a population of CD34(+) cells isolated from PLC/PRF/5 h... | BeFree | 25519836 | Detail |
<0.001 | Fibrous papule of face | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Nonorganic psychosis | NA | BeFree | Detail | |
<0.001 | Pre B-cell acute lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Common acute lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | juvenile myelomonocytic leukemia | In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic ... | BeFree | 25102944 | Detail |
<0.001 | Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
<0.001 | Hematologic Neoplasms | Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in pa... | BeFree | 24680978 | Detail |
<0.001 | Severe combined immunodeficiency due to adenosine deaminase deficiency | NA | BeFree | Detail | |
0.004 | dermatofibrosarcoma protuberans | NA | BeFree | Detail | |
<0.001 | Immune thrombocytopenic purpura | NA | BeFree | Detail | |
<0.001 | Trisomy 12 | NA | BeFree | Detail | |
0.002 | Chromosome 8, trisomy | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Acute myeloid leukemia, minimal differentiation | NA | BeFree | Detail | |
<0.001 | Hepatitis B, Chronic | Entecavir promotes CD34⁺ stem cell proliferation in the peripheral blood and liv... | BeFree | 25425463 | Detail |
<0.001 | Malignant neoplasm of esophagus | NA | BeFree | Detail | |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Ewings sarcoma | NA | BeFree | Detail | |
<0.001 | Carcinogenesis | MiRNAs are characteristically expressed in tumor-initiating Sca-1(+) CD34(+) cel... | BeFree | 25359683 | Detail |
<0.001 | hyperhomocysteinemia | CD34(+) PC transfusion partially reversed HHcy-suppressed re-endothelialization ... | BeFree | 25854700 | Detail |
0.001 | Leukemogenesis | NA | BeFree | Detail | |
0.003 | myelofibrosis | Here, we show that treatment with the dual phosphoinositide-3-kinase (PI3K)/AKT ... | BeFree | 23445613 | Detail |
0.006 | polycythemia vera | Genetic or PAD-mediated PP2A reactivation induces Jak2(V617F) inactivation/downr... | BeFree | 23926298 | Detail |
0.009 | Primary myelofibrosis | The present data suggests the JAK2 V617F allele burden as a key determinant of t... | BeFree | 17961178 | Detail |
0.002 | Myeloproliferative disease | We conclude that the extent of JAK2(V617F) CD34(+) cell clonal dominance is asso... | BeFree | 18723264 | Detail |
0.002 | Thrombocythemia, Essential | CD34(+) cell JAK2(V617F) clonal dominance, defined as coherence between the CD34... | BeFree | 18723264 | Detail |
0.009 | Primary myelofibrosis | Here, we show that treatment with the dual phosphoinositide-3-kinase (PI3K)/AKT ... | BeFree | 23445613 | Detail |
0.009 | Primary myelofibrosis | CD34(+) cell JAK2(V617F) clonal dominance, defined as coherence between the CD34... | BeFree | 18723264 | Detail |
0.002 | Myeloproliferative disease | BMS-911543 is a JAK2-selective inhibitor that induces apoptosis in JAK2-dependen... | BeFree | 25912019 | Detail |
0.002 | breast carcinoma | NA | BeFree | Detail | |
0.006 | polycythemia vera | A JAK2 (V617F) gene dosage effect on both CD34(+) cell counts and granulocyte ac... | BeFree | 16373657 | Detail |
0.001 | Chronic myeloproliferative disorder | BMS-911543 is a JAK2-selective inhibitor that induces apoptosis in JAK2-dependen... | BeFree | 25912019 | Detail |
0.002 | Myeloproliferative disease | We studied the relationship between granulocyte JAK2 (V617F) mutation status, ci... | BeFree | 16373657 | Detail |
0.002 | Myeloproliferative disease | Multiple iPS cell lines were also generated from peripheral blood CD34(+) cells ... | BeFree | 19797525 | Detail |
<0.001 | Myeloid Metaplasia | The present data suggests the JAK2 V617F allele burden as a key determinant of t... | BeFree | 17961178 | Detail |
0.006 | polycythemia vera | We conclude that the extent of JAK2(V617F) CD34(+) cell clonal dominance is asso... | BeFree | 18723264 | Detail |
0.005 | Blast Phase | Absence of the JAK2 mutation V617F in CD34+ hematopoietic stem and progenitor ce... | BeFree | 16442619 | Detail |
<0.001 | Carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
0.002 | stomach carcinoma | NA | BeFree | Detail | |
0.002 | Central neuroblastoma | Neuroblastoma arginase activity results in inhibition of myeloid cell activation... | BeFree | 26054597 | Detail |
<0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
<0.001 | 5q-syndrome | NA | BeFree | Detail | |
<0.001 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Malignant Squamous Cell Neoplasm | NA | BeFree | Detail | |
<0.001 | Small Lymphocytic Lymphoma | NA | BeFree | Detail | |
<0.001 | Philadelphia chromosome positive | NA | BeFree | Detail | |
<0.001 | Chronic graft-versus-host disease | NA | BeFree | Detail | |
0.002 | latent infection | This finding, although not conclusive due to the low number of patients examined... | BeFree | 25658531 | Detail |
<0.001 | Cardiomyopathies | The highest B19V DNA concentrations were found in CD34(+)KDR(+) cells from 17 pa... | BeFree | 25805750 | Detail |
<0.001 | ovarian neoplasm | NA | BeFree | Detail | |
<0.001 | cancer regression | NA | BeFree | Detail | |
<0.001 | Bone marrow toxicity | NA | BeFree | Detail | |
<0.001 | Invasive Ductal Breast Carcinoma | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
<0.001 | Myxoid cyst | The ganglion-like cells were positive for both CD34 and CD68 but negative for CD... | BeFree | 24857338 | Detail |
0.002 | Anemia, Diamond-Blackfan | NA | BeFree | Detail | |
0.004 | sarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Refractory anemia with ringed sideroblasts | NA | BeFree | Detail | |
0.002 | Solitary fibrous tumor | In summary, when encountering a bland spindle cell neoplasm with classic hemangi... | BeFree | 25416841 | Detail |
0.002 | Solitary fibrous tumor | FDG PET/CT and MR imaging of CD34-negative soft-tissue solitary fibrous tumor wi... | BeFree | 25667482 | Detail |
<0.001 | dysembryoplastic neuroepithelial tumor | NA | BeFree | Detail | |
<0.001 | Low-grade fibromyxoid sarcoma | In summary, when encountering a bland spindle cell neoplasm with classic hemangi... | BeFree | 25416841 | Detail |
0.003 | X-Linked Combined Immunodeficiency Diseases | NA | BeFree | Detail | |
0.002 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Myelodysplastic Syndrome with Isolated del(5q) | NA | BeFree | Detail | |
<0.001 | Therapy-related myelodysplastic syndrome | NA | BeFree | Detail | |
<0.001 | blastic plasmacytoid dendritic cell neoplasm | NA | BeFree | Detail | |
<0.001 | Infantile malignant osteopetrosis | NA | BeFree | Detail | |
<0.001 | Secondary polycythemia | NA | BeFree | Detail | |
<0.001 | M5b Acute differentiated monocytic leukemia | NA | BeFree | Detail | |
<0.001 | congenital amegakaryocytic thrombocytopenia | NA | BeFree | Detail | |
<0.001 | Dermal Fibroma | NA | BeFree | Detail | |
<0.001 | Gastric Gastrointestinal Stromal Tumor | NA | BeFree | Detail | |
<0.001 | Invasive Carcinoma | NA | BeFree | Detail | |
<0.001 | Lipomatous hemangiopericytoma | NA | BeFree | Detail | |
<0.001 | pulmonary sclerosing hemangioma | NA | BeFree | Detail | |
<0.001 | mesenchymal cell neoplasm | Immunocytochemical staining demonstrated positive results for vimentin, CD31, an... | BeFree | 24166896 | Detail |
<0.001 | Mixed Cell Type Gastrointestinal Stromal Tumor | NA | BeFree | Detail | |
<0.001 | Spindle Cell Neoplasm | In summary, when encountering a bland spindle cell neoplasm with classic hemangi... | BeFree | 25416841 | Detail |
<0.001 | Treatment related acute myeloid leukaemia | NA | BeFree | Detail | |
0.001 | Undifferentiated leukemia | For patients with ALDH-numerous AML, the CD34(+) ALDH(+) subset consisted mainly... | BeFree | 25545165 | Detail |
<0.001 | Vascular lesions | NA | BeFree | Detail | |
<0.001 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
<0.001 | Human T-cell lymphotropic virus 1 infection | NA | BeFree | Detail | |
<0.001 | Tumor-Associated Vasculature | NA | BeFree | Detail | |
<0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
<0.001 | colorectal cancer | NA | BeFree | Detail | |
<0.001 | Nephrogenic Fibrosing Dermopathy | NA | BeFree | Detail | |
<0.001 | Cirrhosis | A significant increase in both CD34⁺ and CD133⁺ cells was found in CHB and cirrh... | BeFree | 25425463 | Detail |
0.001 | tumor vasculature | NA | BeFree | Detail | |
<0.001 | Direct Contact Transmission Infection | NA | BeFree | Detail | |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
<0.001 | Idiopathic Pulmonary Fibrosis | NA | BeFree | Detail | |
<0.001 | Chromosome 5, trisomy 5q | NA | BeFree | Detail | |
<0.001 | THROMBOCYTOPENIA 1 (disorder) | NA | BeFree | Detail | |
<0.001 | IMMUNE SUPPRESSION | NA | BeFree | Detail | |
0.001 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
0.001 | severe congenital neutropenia | NA | BeFree | Detail | |
<0.001 | SCID Due to ADA Deficiency, Early-Onset | NA | BeFree | Detail | |
<0.001 | Partial adenosine deaminase deficiency | NA | BeFree | Detail | |
<0.001 | Quebec platelet disorder | NA | BeFree | Detail | |
<0.001 | coronary artery disease | NA | BeFree | Detail | |
<0.001 | Parvovirus B19 (disease) | The highest B19V DNA concentrations were found in CD34(+)KDR(+) cells from 17 pa... | BeFree | 25805750 | Detail |
0.001 | Philadelphia chromosome-positive acute lymphoblastic leukemia | NA | BeFree | Detail | |
0.002 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | In addition, we generated long non-coding RNA expression profiles (array data) f... | BeFree | 25344525 | Detail |
0.011 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged hu... | BeFree,LHGDN | 25538041 | Detail |
<0.001 | Gaucher Disease, Type 1 | NA | BeFree | Detail | |
<0.001 | Urothelial Carcinoma | NA | BeFree | Detail | |
0.006 | liver carcinoma | Samples from 53 patients with HCC, i.e., 5 with metastasis and 48 without were t... | BeFree,GAD | 25337219 | Detail |
0.006 | liver carcinoma | Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that resu... | BeFree,GAD | 25519836 | Detail |
0.006 | liver carcinoma | Here, based on the analysis of HCC datasets from Gene Expression Omnibus (GEO) d... | BeFree,GAD | 25701390 | Detail |
<0.001 | Chronic thromboembolic pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Extramedullary Hematopoiesis (disorder) | Our data indicate that the MF splenic microenvironment is characterized by incre... | BeFree | 25461253 | Detail |
<0.001 | Hyperdiploid B Acute Lymphoblastic Leukemia | NA | BeFree | Detail | |
<0.001 | Mixed phenotype acute leukemia | NA | BeFree | Detail | |
<0.001 | Clear-cell metastatic renal cell carcinoma | Formalin-fixed, paraffin-embedded tissue sections of clear cell RCC from 73 pati... | BeFree | 25142236 | Detail |
<0.001 | Refractory anemia, without ringed sideroblasts, without excess blasts | NA | BeFree | Detail | |
0.007 | myelodysplastic syndrome | Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in M... | BeFree,LHGDN | 25122688 | Detail |
0.007 | myelodysplastic syndrome | In the study presented here, the International Prognostic Scoring Systems were v... | BeFree,LHGDN | 25344522 | Detail |
0.002 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
<0.001 | Homocysteinemia | CD34(+) PC transfusion partially reversed HHcy-suppressed re-endothelialization ... | BeFree | 25854700 | Detail |
<0.001 | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | NA | BeFree | Detail | |
<0.001 | Giant Cell Fibroblastoma | Subsequent histologic features were consistent with GCF, which is an uncommon, C... | BeFree | 25088682 | Detail |
<0.001 | Acute-On-Chronic Liver Failure | NA | BeFree | Detail | |
<0.001 | Congenital Abnormality | NA | BeFree | Detail | |
0.003 | adenocarcinoma | NA | LHGDN | Detail | |
<0.001 | adenoma | NA | BeFree | Detail | |
0.009 | Primary myelofibrosis | A histone deacetylase inhibitor, panobinostat, significantly increased MIRLET7 e... | BeFree,LHGDN | 25236537 | Detail |
0.009 | Primary myelofibrosis | Our data indicate that the MF splenic microenvironment is characterized by incre... | BeFree,LHGDN | 25461253 | Detail |
<0.001 | extrinsic allergic alveolitis | NA | BeFree | Detail | |
<0.001 | Alzheimer's disease | NA | BeFree | Detail | |
<0.001 | anemia | NA | BeFree | Detail | |
0.002 | aplastic anemia | CD34(+) cells were comparably reduced in GATA2 and AA. | BeFree | 25359990 | Detail |
<0.001 | Cooley's anemia | NA | BeFree | Detail | |
<0.001 | Refractory anemias | NA | BeFree | Detail | |
0.002 | Refractory anaemia with excess blasts | NA | BeFree | Detail | |
0.002 | Anemia, Sickle Cell | Transgenic expression of LIN28A was accomplished by lentiviral transduction in C... | BeFree | 25188417 | Detail |
0.002 | Anemia, Sickle Cell | Importantly, ZFN-driven gene correction in CD34(+) cells from the bone marrow of... | BeFree | 25733580 | Detail |
<0.001 | Aneurysm | NA | BeFree | Detail | |
<0.001 | cutaneous fibrous histiocytoma | NA | BeFree | Detail | |
<0.001 | arteriosclerosis | NA | BeFree | Detail | |
<0.001 | Congenital arteriovenous malformation | After the monolayer adherent ECs reached confluence, they were tested with endot... | BeFree | 24771337 | Detail |
0.001 | rheumatoid arthritis | NA | BeFree | Detail | |
0.001 | asthma | NA | BeFree | Detail | |
<0.001 | atherosclerosis | NA | BeFree | Detail | |
0.001 | beta thalassemia | NA | BeFree | Detail | |
0.005 | Blast Phase | NA | BeFree | Detail | |
<0.001 | Blood Platelet Disorders | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of breast | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
<0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
<0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
<0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The presence of FAM18B was determined with qRT-PCR in CD34+/VEGFR2+ mononuclear cells isolated from ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using a standard platform that combines iPSC generation from peripheral blood CD34(+) cells and ZFN ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In summary, when encountering a bland spindle cell neoplasm with classic hemangiopericytoma-like blo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Gene therapy for hematological disorders relies on the genetic modification of CD34(+) cells, a hete... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our strategy underlines the promising future of gene engineering HIV-resistant CD34(+) cells that pr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Day-7-cultured CD34(+) cells from two of three JMML patients injected intrafemorally into immunodefi... | DisGeNET | Detail |
Transduction of unstimulated CD34(+) cells with CD133-LV resulted in gene marking of cells with comp... | DisGeNET | Detail |
In order to understand the precise mechanisms involved in human APL leukemogenesis, we established a... | DisGeNET | Detail |
Here, we determined that a population of CD34(+) cells isolated from PLC/PRF/5 hepatoma cells (PLC) ... | DisGeNET | Detail |
Human CD34(+) human cord blood cells were transduced with an FV vector encoding a methylguanine meth... | DisGeNET | Detail |
NA | DisGeNET | Detail |
CD34 and CD49b are cell surface markers that can be used to enrich a subpopulation of leiomyoma cell... | DisGeNET | Detail |
Primitive CD34(+)/CD123(+)/CD38(-) populations enriched for leukemia-initiating progenitors, but not... | DisGeNET | Detail |
Including cytogenetic data of fluorescence in situ hybridization analyses of peripheral CD34(+) bloo... | DisGeNET | Detail |
In MLL-AF4 patients, CD34(+)CD38(+)CD19(+) and CD34(-)CD19(+) cells initiated leukemia, and in MLL-A... | DisGeNET | Detail |
Ectopic expression of SOX7 in K562 and THP-1 cells, as well as primary CD33(+)CD34(+) AML cells, abr... | DisGeNET | Detail |
Expression of TP53 by CD34-positive cells was associated with shorter OS and leukaemia-free survival... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblas... | DisGeNET | Detail |
We analyzed cells from peripheral blood and CD34-/CD34+ cells from bone marrow of pediatric acute ly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We analyzed the expression of RIP1 and RIP3 in CD34+ leukemia cells from a cohort of patients with a... | DisGeNET | Detail |
In the mice implanted with AML CD34+ HSPCs, expression inhibition of the miR-181 family by Lenti-miR... | DisGeNET | Detail |
More importantly, curcumin suppressed FoxM1 expression, selectively inhibited cell survival as well ... | DisGeNET | Detail |
CD34(+) cells from a subset of AML patients displayed higher expression levels of CITED2 as compared... | DisGeNET | Detail |
We performed RNA sequencing of 12 EVI1-r AMLs and compared the results with those of other AML subty... | DisGeNET | Detail |
In this analysis, we have examined the value of aldehyde dehydrogenase (ALDH) activity in combinatio... | DisGeNET | Detail |
Epigenetic analysis of a subset of AML samples also identified common regions of chromatin accessibi... | DisGeNET | Detail |
Ectopic expression of SOX7 in K562 and THP-1 cells, as well as primary CD33(+)CD34(+) AML cells, abr... | DisGeNET | Detail |
We recently found that the tetraspanin family member, CD82, which is aberrantly expressed in chemoth... | DisGeNET | Detail |
In this study, we report that the expression of the key miRNA processing enzyme DICER1 is down-regul... | DisGeNET | Detail |
Signal transducer and activator of transcription 5 (STAT5) is activated in CD34(+)/CD38(-) acute mye... | DisGeNET | Detail |
Now, our results indicate that high PKR expression in CD34(+) cells of acute myeloid leukemia (AML) ... | DisGeNET | Detail |
Cord Blood-Derived Quiescent CD34+ Cells Are More Transcriptionally Matched to AML Blasts Than Cytok... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Herein, novel polyelectrolyte complexes were used as model carriers for IM in a CML cell line (KU812... | DisGeNET | Detail |
Bosutinib/PF-00477736 co-treatment also potentiated cell death in CD34(+) CML patient samples, inclu... | DisGeNET | Detail |
Using microarray-based miRNA profiling, we found that miRNA 486 (miR-486) is significantly upregulat... | DisGeNET | Detail |
Moreover, CC(mut3) inhibits colony formation by primary CML CD34(+) cells ex vivo, including a sampl... | DisGeNET | Detail |
The aim of the study was to identify specific features of functional activity, proliferation rates a... | DisGeNET | Detail |
Also, ectopic expression of CCNG2 in CD34+ CML cells strongly decreased their clonogenicity. | DisGeNET | Detail |
A similar mechanism was found to operate in primary CML CD34(+) cells. | DisGeNET | Detail |
Moreover, BAP1 protein levels are low or undetectable in CD34(+) cells from CML patients at diagnosi... | DisGeNET | Detail |
In addition, miR-181a increased IM sensitivity of the CD34+ CML cells. | DisGeNET | Detail |
Expression of IK6 in CD34(+) CP-CML cells also led to activation of signal transducer and activator ... | DisGeNET | Detail |
GATA2 mutations were closely associated with younger age, FAB M1 subtype, intermediate-risk cytogene... | DisGeNET | Detail |
RNA-seq analyses of telomere dysfunctional CMP identified aberrantly spliced transcripts linked to p... | DisGeNET | Detail |
These findings demonstrate that CMP are a target fraction for PML-RARA in APL, whereas the resultant... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A significant increase in both CD34⁺ and CD133⁺ cells was found in CHB and cirrhosis patients compar... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenito... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our data indicate that the MF splenic microenvironment is characterized by increased levels of intac... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Samples from 53 patients with HCC, i.e., 5 with metastasis and 48 without were tested for Notch1(+) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Neuroblastoma arginase activity results in inhibition of myeloid cell activation and suppression of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
They putatively infiltrate the orbit in thyroid-associated ophthalmopathy where they appear to trans... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndr... | DisGeNET | Detail |
In the study presented here, the International Prognostic Scoring Systems were validated based on fl... | DisGeNET | Detail |
NA | DisGeNET | Detail |
CD34+/VEGFR2+ mononuclear cells from subjects with proliferative diabetic retinopathy demonstrated s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HMGA2 mRNA expression, especially variant 1 with 3'UTR that contains MIRLET7-specific sites, rather ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CD34 and CD49b are cell surface markers that can be used to enrich a subpopulation of leiomyoma cell... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Human CD34(+) human cord blood cells were transduced with an FV vector encoding a methylguanine meth... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The ganglion-like cells were positive for both CD34 and CD68 but negative for CD30. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MiRNAs are characteristically expressed in tumor-initiating Sca-1(+) CD34(+) cells of lung adenocarc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CD34+/VEGFR2+ mononuclear cells from subjects with proliferative diabetic retinopathy demonstrated s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recently, we demonstrated that of the cell types derived from CD34+ stem cells, predominantly monocy... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunohistochemistry analysis showed that the NEC tumor cells were positive for CK (cytokeratin), CD... | DisGeNET | Detail |
CD34(+) PLCs that also expressed CD31 and their progeny CD31(+) cells formed CHCs. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The pathology showed a gastrointestinal stromal tumor that was diagnosed based on positive immunosta... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MDS-derived MSCs exhibited impaired capacity to support normal CD34(+) myeloid and erythroid colony ... | DisGeNET | Detail |
MDS is a disorder of the hematopoietic stem cell and we thus studied the transcriptome of CD34(+) ce... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we determined that a population of CD34(+) cells isolated from PLC/PRF/5 hepatoma cells (PLC) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
For patients with ALDH-numerous AML, the CD34(+) ALDH(+) subset consisted mainly of LSC and separati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The perivascular distribution of periostin and tenascin-C, associated with the CD34 positivity, sugg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
They putatively infiltrate the orbit in thyroid-associated ophthalmopathy where they appear to trans... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we determined that a population of CD34(+) cells isolated from PLC/PRF/5 hepatoma cells (PLC) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AG... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematolo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Entecavir promotes CD34⁺ stem cell proliferation in the peripheral blood and liver of chronic hepati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MiRNAs are characteristically expressed in tumor-initiating Sca-1(+) CD34(+) cells of lung adenocarc... | DisGeNET | Detail |
CD34(+) PC transfusion partially reversed HHcy-suppressed re-endothelialization and HHcy-induced neo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we show that treatment with the dual phosphoinositide-3-kinase (PI3K)/AKT and mTOR inhibitor B... | DisGeNET | Detail |
Genetic or PAD-mediated PP2A reactivation induces Jak2(V617F) inactivation/downregulation and impair... | DisGeNET | Detail |
The present data suggests the JAK2 V617F allele burden as a key determinant of the degree of myelopr... | DisGeNET | Detail |
We conclude that the extent of JAK2(V617F) CD34(+) cell clonal dominance is associated with disease ... | DisGeNET | Detail |
CD34(+) cell JAK2(V617F) clonal dominance, defined as coherence between the CD34(+) cell and neutrop... | DisGeNET | Detail |
Here, we show that treatment with the dual phosphoinositide-3-kinase (PI3K)/AKT and mTOR inhibitor B... | DisGeNET | Detail |
CD34(+) cell JAK2(V617F) clonal dominance, defined as coherence between the CD34(+) cell and neutrop... | DisGeNET | Detail |
BMS-911543 is a JAK2-selective inhibitor that induces apoptosis in JAK2-dependent cell lines and inh... | DisGeNET | Detail |
NA | DisGeNET | Detail |
A JAK2 (V617F) gene dosage effect on both CD34(+) cell counts and granulocyte activation was clearly... | DisGeNET | Detail |
BMS-911543 is a JAK2-selective inhibitor that induces apoptosis in JAK2-dependent cell lines and inh... | DisGeNET | Detail |
We studied the relationship between granulocyte JAK2 (V617F) mutation status, circulating CD34(+) ce... | DisGeNET | Detail |
Multiple iPS cell lines were also generated from peripheral blood CD34(+) cells of 2 patients with m... | DisGeNET | Detail |
The present data suggests the JAK2 V617F allele burden as a key determinant of the degree of myelopr... | DisGeNET | Detail |
We conclude that the extent of JAK2(V617F) CD34(+) cell clonal dominance is associated with disease ... | DisGeNET | Detail |
Absence of the JAK2 mutation V617F in CD34+ hematopoietic stem and progenitor cells from patients wi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Neuroblastoma arginase activity results in inhibition of myeloid cell activation and suppression of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This finding, although not conclusive due to the low number of patients examined, adds further evide... | DisGeNET | Detail |
The highest B19V DNA concentrations were found in CD34(+)KDR(+) cells from 17 patients with chronic ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The ganglion-like cells were positive for both CD34 and CD68 but negative for CD30. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In summary, when encountering a bland spindle cell neoplasm with classic hemangiopericytoma-like blo... | DisGeNET | Detail |
FDG PET/CT and MR imaging of CD34-negative soft-tissue solitary fibrous tumor with NAB2-STAT6 fusion... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In summary, when encountering a bland spindle cell neoplasm with classic hemangiopericytoma-like blo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunocytochemical staining demonstrated positive results for vimentin, CD31, and CD34 and negative ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In summary, when encountering a bland spindle cell neoplasm with classic hemangiopericytoma-like blo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
For patients with ALDH-numerous AML, the CD34(+) ALDH(+) subset consisted mainly of LSC and separati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A significant increase in both CD34⁺ and CD133⁺ cells was found in CHB and cirrhosis patients compar... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The highest B19V DNA concentrations were found in CD34(+)KDR(+) cells from 17 patients with chronic ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, we generated long non-coding RNA expression profiles (array data) from ex vivo isolated... | DisGeNET | Detail |
Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Samples from 53 patients with HCC, i.e., 5 with metastasis and 48 without were tested for Notch1(+) ... | DisGeNET | Detail |
Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that result in three types of... | DisGeNET | Detail |
Here, based on the analysis of HCC datasets from Gene Expression Omnibus (GEO) database and The Canc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our data indicate that the MF splenic microenvironment is characterized by increased levels of intac... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Formalin-fixed, paraffin-embedded tissue sections of clear cell RCC from 73 patients who had undergo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndr... | DisGeNET | Detail |
In the study presented here, the International Prognostic Scoring Systems were validated based on fl... | DisGeNET | Detail |
NA | DisGeNET | Detail |
CD34(+) PC transfusion partially reversed HHcy-suppressed re-endothelialization and HHcy-induced neo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Subsequent histologic features were consistent with GCF, which is an uncommon, CD34 positive, soft t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A histone deacetylase inhibitor, panobinostat, significantly increased MIRLET7 expression and reduce... | DisGeNET | Detail |
Our data indicate that the MF splenic microenvironment is characterized by increased levels of intac... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CD34(+) cells were comparably reduced in GATA2 and AA. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Transgenic expression of LIN28A was accomplished by lentiviral transduction in CD34(+) sickle cells ... | DisGeNET | Detail |
Importantly, ZFN-driven gene correction in CD34(+) cells from the bone marrow of patients with SCD r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
After the monolayer adherent ECs reached confluence, they were tested with endothelial specific mark... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg19
- Position
- chr1:208,054,317-208,084,747
- Variant Type
- snv
Genome browser